在先天性肌肉衰竭综合征的创新治疗方法
Mohamed I Kediha1, Meriem Tazir1, Damien Sternberg1
1Neurology Department (MIK, MT, LAP), Mustapha Bacha University Hospital Algiers, Algeria; Myology Department (DS), Pitié Salpetriere, Paris; and Functional Unit for Neuromuscular Pathology (BE), Pitié Salpetriere, France.
Neurology. Clinical practice
|May 13, 2024
概括
创新的治疗方法为患有先天性肌痛综合征 (CMS) 的患者提供了显著的临床改善. 这项研究突出了这种罕见的神经肌肉疾病的传统皮里多斯提格之外的有效治疗选择.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 先天性肌痛综合征 (CMS) 是一种罕见的遗传疾病,影响神经肌肉传播.
- 传统的CMS治疗方法有局限性,需要探索新的治疗策略.
研究的目的:
- 介绍有关先天性肌痛综合征 (CMS) 患者的实际临床随访数据.
- 评估创新药物在治疗具有多种遗传突变和病理生理特征的CMS患者中的疗效.
主要方法:
- 招募了6名具有遗传确认的CMS和不同突变类型的患者.
- 通过临床评估,电肌谱和遗传研究来评估临床进展.
- 患者接受了创新药物,这些药物通常不适用于神经疾病.
主要成果:
- 所有六名患者在接受创新药物治疗后都表现出明显的临床改善.
- 该研究包括患有各种CMS亚型的患者,包括缓慢通道,快速通道和低表达体综合征.
- 观察到的结果表明对新型治疗干预措施的积极反应.
结论:
- 创新的药物治疗方法,除了皮里多斯提格,可以显著改善先天性肌痛综合征患者的治疗结果.
- 这些发现强调了重新利用非神经药物来治疗这种孤儿疾病的潜力.
- 第四类证据支持这些创新的治疗方法在CMS管理中的有效性.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Myasthenia Gravis: Diagnostic Tests
791
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
791
Skeletal Muscle Relaxants: Therapeutic Uses
481
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
481
Direct-Acting Cholinergic Agonists: Therapeutic Uses
731
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
731
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
661
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
661
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
674
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
674


